Directorate of Drugs Control (DDC), Punjab — Drug Alerts: Class I & II Recalls and Prompt Alert

On 12 October 2026 and 16 October 2026, the Directorate of Drugs Control (DDC), Punjab, issued three drug alerts concerning substandard and spurious pharmaceutical products. These include Class I and Class II Medicine Recalls and a Prompt Alert.

The notices identify the affected products and batches and outline the necessary regulatory actions to protect public health and patient safety.

1. Medicine Recall — Class II

DDCP Alert No. 150/2026 | Date: 16.10.2026

Issuing Authority: Government of the Punjab, Directorate of Drugs Control (DDC), Punjab.
Problem Statement: The Drug Testing Laboratories Punjab declared the products listed below as Substandard. The Provincial Quality Control Board, Punjab, directed the issuance of a recall for these products.

Drug Alerts Details

Medication: 1

Product Name: Tab. Librax
Composition: Each dragee contains:
- Chlordiazepoxide 5mg
- Clidinium bromide 2.5mg
Registration Number: 000568
Batch Number: 001952
Expiry Date: December 2028
Manufacturer: M/s Martin Dow Limited, Plot 37, Sector 19, Korangi Industrial Area, Karachi-74900, Pakistan.
Under Licence From: Meda Pharma GmbH & Co. KG.
Reason for Recall: Declared “Substandard” on the basis of the Impurity Test.
Test Reference: TRA No. 01-68037608/DTL
Test Date: 13.10.2026

Medication: 2

- Product Name: Inj. Carapamin 5mL
- Composition: Dopamine Hydrochloride 200mg/5ml
- Registration Number: 060235
- Batch Number: 26A059
- Expiry Date: December 2027
- Manufacturer: M/s Caraway Pharmaceuticals, Plot 12, St # 3, National Industrial Zone (RCCI), Rawat, Islamabad.
- Reason for Recall: Declared “Substandard” on the basis of Organic Impurities.
- Test Reference: TRA No. 01-141006773/DTL
- Test Date: 10.10.2026

2. Medicine Recall — Class I

DDCP Alert No. 151/2026 | Date: 16.10.2026

Issuing Authority: Government of the Punjab, Directorate of Drugs Control (DDC), Punjab.
Problem Statement: The Drug Testing Laboratory Punjab declared the product listed below as Substandard. The Provincial Quality Control Board, Punjab, directed the issuance of a recall.

Drug Alerts detail

- - Product Name: Sterile Disposable, Cikina Umbilical Cord Clamp
  - Registration Number: MDIR-0003486
  - Batch Number: 25495
  - Expiry Date: March 2031
  - Manufacturer: M/s Ningbo Greatcare Trading Co. Ltd., Unit 93, Building 12, No. 818, Qiming Road, Yinzhou 315105, Ningbo, Zhejiang, China.
  - Marketed by: M/s Al-Hamd Enterprises, FL-11/1/1, Block-6, Gulshan-e-Iqbal, Karachi-Pakistan.
  - License Number: ELI-00285
  - Reason for Recall: Declared “Substandard” with respect to the Sterility Test.
  - Test Reference: TRA No. 01-75015076/DTL
  - Test Date: 13.10.2026

3. Prompt Alert — Class I

DDCP Alert No. 147/2026 | Date: 12.10.2026

Issuing Authority: Government of the Punjab, Directorate of Drugs Control, Punjab.
Problem Statement: The Drug Testing Laboratory, Punjab, declared the product listed below as Spurious. The Provincial Quality Control Board, Punjab, directed the issuance of a Prompt Alert.

Product details

Product Name: Dressing. Septi Grass Tulle
Size: 10cm x 10cm NLT5%.
Description: Chlorhexidine Tulle; Antiseptic Tulle Grass Dressing for Wounds.
Content: Chlorhexidine Acetate 0.4%-0.6% w/w
Registration Number: MDMR-000226
Batch Number: SG-036
Expiry Date: January 2031
Manufacturer: M/s Karim Industries, 1/2 Km, Raiwind Lahore Road, Raiwind, District Lahore, Pakistan.
Supply Category: Government Supply
Reason for Alert: Declared “Spurious” under the Drugs Act 1976, on the basis of the content of Chlorhexidine Acetate.
Test Reference: TRA No. 01-10119001608/DTL
Test Date: 10.10.2026

1. Instructions for the Market Authorization Holder (MAH)/Importer/Distributor

Immediately initiate the recall of the affected batches, wherever applicable, and ensure that the products are removed from the market.
Provide complete distribution records and supply-chain details to the relevant regulatory authorities.
Upload the Recall Assessment Form on the DRAP website at https://dra.gov.pk/publications/application-forms/#Recall for the applicable recall alerts.
Conduct a detailed root cause analysis and prepare a Corrective and Preventive Action (CAPA) plan for products declared substandard.
For products declared spurious, review the supply chain and distribution records, verify authorized sources, and report any suspicious or unauthorized activity to the relevant regulatory authority.
Submit all required reports, recall documentation, and supporting evidence to the competent authorities.

2. Instructions for Healthcare Professionals and Regulators

Pharmacies, medical stores, wholesalers, distributors, and healthcare facilities must immediately stop dispensing or supplying the affected products and batches.
Identify and segregate the available stock and report inventory and consumption records to the respective Drug Inspector or relevant regulatory authority.
Drug regulatory field formations in Punjab must enhance market surveillance, verify distribution records, and take appropriate regulatory action in accordance with the Drugs Act, 1976, the DRAP Act, 2012, and the applicable rules.
For products declared spurious, conduct appropriate investigations, seize the products where warranted, and report non-compliance to the competent authority.
Submit comprehensive reports to the Chief Drugs Controller, Punjab, for onward submission to the concerned authorities.

3. Advice for Consumers/General Public

Immediately stop using the affected products and batches identified in the alerts, as their quality, safety, or authenticity may be compromised.
Consumers possessing the affected products should discontinue their use and consult a qualified healthcare professional regarding suitable alternatives.
Purchase medicines and therapeutic goods only from authorized pharmacies and reliable sources.
Report any suspected adverse effects associated with these products to the Provincial Pharmacovigilance Centre through the Medicine Surveillance System (MSS): https://mss.pshealthpunjab.gov.pk